SEO URLwww.firestrike.ai/deals/british-dark-blue-therapeutics-amgen-acquisition-2026
acquisitionAnnounced · Jan 8, 2026BiotechnologySource · AdvertisementsArticle · Factual
Amgen acquires British Dark Blue Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$840M
Target
British Dark Blue Therapeutics
Acquirer
Amgen
Full Acquisition
Status
Announced
Amgen agreed to acquire British Dark Blue Therapeutics. Reported deal value: $840M. Status: Announced. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-08. Figures and status may change as filings and press coverage update.
Read more in our Amgen acquires British Dark Blue Therapeutics for USD 840m Amgen strengthens cancer research with acquisition of Dark Blue Therapeutics
Deal timeline
Announced
Jan 8, 2026 · medwatch.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $840M. Figures and status may change as sources update.
Sources: medwatch.com · Primary article · FireStrike proprietary index